Relay Therapeutics, Inc. RLAY
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-07-16
Relay Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 10,542,667 | $68.7M | 6.06% |
| TWO SIGMA INVESTMENTS, LP | 1,369,149 | $13.6M | 0.79% |
| AQR CAPITAL MANAGEMENT LLC | 1,290,032 | $12.8M | 0.74% |
| RENAISSANCE TECHNOLOGIES LLC | 673,599 | $6.7M | 0.39% |
| MILLENNIUM MANAGEMENT LLC | 347,733 | $3.5M | 0.2% |
| CITADEL ADVISORS LLC | 202,365 | $2.0M | 0.12% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.